Detecting Metastatic Prostate Cancer Risk in Black Men
To explore why prostate cancer disproportionately harms Black men, researchers looked to another disorder, diabetes, which alters metabolism.
Read MorePosted by Andy Lundin | Aug 15, 2023 | Prostate |
To explore why prostate cancer disproportionately harms Black men, researchers looked to another disorder, diabetes, which alters metabolism.
Read MorePosted by Andy Lundin | Aug 7, 2023 | Cardiovascular |
The FDA cleared the AXINON LDL-p Test System as a tool physicians can use to measure lipoproteins for those at risk of cardiovascular disease.
Read MorePosted by Chris Wolski | Aug 7, 2023 | Diabetes & Metabolic Diseases |
While A1c is the diagnostic gold standard for determining if a patient has diabetes, there are a variety of tests that provide flexibility.
Read MorePosted by Andy Lundin | Jul 21, 2023 | Clinical Chemistry Test Kits, Immunoassay |
The Atellica CI Analyzer for immunoassay and clinical chemistry testing received FDA clearance and is now available in many major markets.
Read MorePosted by Andy Lundin | Jul 20, 2023 | Dementias & Alzheimer’s |
A simple, finger prick blood test shows promise in the ability to detect Alzheimer’s disease, according to new research.
Read More